Evidence map›Paper›PMID 36731872›Full record

ArticleACS nano2023

Cell-Free Expression of

Shoko Fujita, Izuru Kawamura, Ryuji Kawano

Abstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Negative design enables cell-free expression and folding of designed transmembrane β-barrels.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shoko FujitaDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo184-8588, Japan.
Izuru KawamuraGraduate School of Engineering Science, Yokohama National University, Yokohama240-8501, Japan.ORCID 0000-0002-8163-9695
Ryuji KawanoDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo184-8588, Japan.ORCID 0000-0001-6523-0649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanopore sensing has attracted much attention as a rapid, simple, and label-free single-molecule detection technology. To apply nanopore sensing to extensive targets including polypeptides, nanopores are required to have a size and structure suitable for the target. We recently designed a

Indexed as

NanoporesNanotechnologyPeptidesPeptidescell-free synthesislipid bilayermolecular dynamics simulationsnanoporepeptide sensing

Identifiers

PMID36731872
PMCPMC9979648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.